Results 201 to 210 of about 72,150 (302)

Cyclophosphamide combined with mitoxantrone and cytarabine is an effective salvage regimen for patients with acute myeloid leukemia who experienced primary induction failure or relapse

, 2015
Shuning Wei, Yingchang Mi, Hui Wei, Dong Lin, KANQI LIU, Benfa Gong, Guangji Zhang, Yuntao Liu, Yan Li, Chunlin Zhou, Bingcheng Liu, Wei Li, Jianxiang Wang   +12 more
openalex   +2 more sources

Supplementary Table 1 from Two Distinct Molecular Mechanisms Underlying Cytarabine Resistance in Human Leukemic Cells

, 2023
Jie Cai, Vijaya L. Damaraju, Normand Groulx, Delores Mowles, Yunshan Peng, Morris J. Robins, Carol E. Cass, Philippe Gros   +7 more
openalex   +1 more source

Supplemental Table S1 from FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia

, 2023
Aviva C. Krauss, Xin Gao, Liang Li, Michael L. Manning, Paresma Patel, Wentao Fu, Kumar G. Janoria, Gerlie Gieser, David Bateman, Donna Przepiorka, Yuan Li Shen, Stacy S. Shord, Christopher M. Sheth, Anamitro Banerjee, Jiang Liu, Kirsten B. Goldberg, Ann T. Farrell, Gideon M. Blumenthal, Richard Pazdur   +18 more
openalex   +1 more source

Novel therapeutic agents and intensive chemotherapy improve survival outcomes in patients with mantle cell lymphoma. [PDF]

Am J Cancer Res
Lin ZC, Wang MC, Lin TL, Kuo MC, Kao HW, Chang H, Hung YS, Ma MC, Ong YC, Ou CW, Kuo CY, Chen YY, Huang YM, Shih HJ.   +13 more
europepmc   +1 more source

Additional file 5 of Radotinib enhances cytarabine (Ara-C)-induced acute myeloid leukemia cell death

, 2020
Sook‐Kyoung Heo, Eui‐Kyu Noh, Ho-Min Yu, Do Kyoung Kim, Hye Jin Seo, Yoo Jin Lee, Jaekyung Cheon, Su Jin Koh, Young Joo Min, Yunsuk Choi, Jae‐Cheol Jo   +10 more
openalex   +1 more source

Central nervous system prophylaxis with intrathecal liposomal cytarabine in diffuse large B‑cell lymphomas [PDF]

, 2013
Katarzyna Krawczyk, Wojciech Jurczak, Monika Długosz‐Danecka, Agnieszka Zauska‐Giza, Justyna Rybka, Tomasz Wróbel, Aleksander B. Skotnicki   +6 more
openalex   +1 more source

Long-term outcomes of pediatric AML in Tunisia: Lessons from 19 years of practice in Sousse. [PDF]

Leuk Res Rep
Bouhoula D, Regaieg H, Abroug H, Sayed NB, Youssef YB.   +4 more
europepmc   +1 more source

Correction: Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia [PDF]

, 2017
Constanze Schneider, Thomas Oellerich, Hanna‐Mari Baldauf, Sarah-Marie Schwarz, Dominique Thomas, Robert Flick, Hanibal Bohnenberger, Lars Kaderali, Lena Stegmann, Anjali Cremer, Margarethe Martin, Julian J.K. Lohmeyer, Martin Michaelis, Veit Hornung, Christoph Schliemann, Wolfgang E. Berdel, Wolfgang Hartmann, Eva Wardelmann, Federico Comoglio, Martin‐Leo Hansmann, Alexander F. Yakunin, Gerd Geißlinger, Philipp Ströbel, Nerea Ferreirós, Hubert Serve, Oliver T. Keppler, Jindřich Činátl   +26 more
openalex   +1 more source

Systemic Toxicity Profile of Chemotherapeutic Agents in a Wistar Rat Model: A Preliminary Report. [PDF]

J Toxicol
Kathare J, Mbaria J, Kaluwa C, Mapenay I, Moriasi G.   +4 more
europepmc   +1 more source

CPX-351 in Down syndrome-associated myeloid leukemia: results and prognostic factors from the phase 3 ML-DS 2018 trial.

Blood
Laszig S, Diederichs A, Salzmann-Manrique E, Schuschel K, Gonçalves-Dias J, Issa H, Miladinovic M, Rettinger E, Wehner S, Kreyenberg H, Bremm M, Hünecke S, Kerp H, Waack-Buchholz K, Thol F, Goemans BF, De Moerloose B, Boztug H, Scheidegger N, Pawińska-Wąsikowska K, Reinhardt D, Klusmann JH.   +21 more
europepmc   +1 more source